Background:
Many guidelines recommend urgent intervention for TIA patients with 2 or episodes within 7-days to reduce the early risk of stroke. However, whether all patients with multiple TIAs are at high early risk of stroke is unknown.
Methods:
Between April 2008 and December 2009, we included 1255 consecutive TIA patients from 30 Spanish stroke centers (PROMAPA study). We prospectively recorded clinical characteristics. We also determined the early short-term risk of stroke (at seven and ninety days). Aetiology of TIA was categorised using the SSS-TOAST classification
Results:
Enough information was assessed in 1137 patients (90.6%). 7-day and 90-day stroke risk were 2.6% and 3.8% respectively. Atherosclerotic etiology (AE) was confirmed in 190 (16.7%) patients. Recurrent TIA was observed in 274 (24,1%) patients. Duration<1 hour (OR 2.94, 95% CI 2.18-3.96, p<0.001), AE (OR 1.97, 95% CI 1.39-2.78, p<0.001) and motor weakness (OR 1.37, 95% CI 1.03-1.82, p<0.029) were independent predictors of recurrent TIA. The subsequent risks of stroke in these patients at 7, and 90 days were significantly higher than those after a single TIA (5.8% versus 1.5%, p<0.001 and 6.8% versus 3.0%, respectively. HR 2.35, 95% CI 1.28-4.31 p=0.006). In the Cox logistic regression model, among patients with recurrent TIA, no variable remained remained as independent predictors of stroke recurrence at 90-day
Conclusion:
According to our results, recurrent TIA within 7-days is associated with a greater subsequent stroke risk than after a single TIA. Nevertheless, we were not able to find any independent predictor of stroke recurrence among these patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.